These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1890312)

  • 21. Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity.
    Wu R; Coleman N; Stanley M
    Chin Med J (Engl); 1996 Nov; 109(11):854-8. PubMed ID: 9275369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity.
    Matsumoto G; Nghiem MP; Nozaki N; Schmits R; Penninger JM
    J Immunol; 1998 Jun; 160(12):5781-9. PubMed ID: 9637488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of lymphokine release and cytolytic activities by activating peripheral blood lymphocytes via CD2.
    Valentin H; Groux H; Gelin C; Chretien I; Bernard A
    J Immunol; 1990 Feb; 144(3):875-82. PubMed ID: 1967277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro.
    Harel W; Shau H; Hadley CG; Morgan AC; Reisfeld RA; Cheresh DA; Mitchell MS
    Cancer Res; 1990 Oct; 50(19):6311-5. PubMed ID: 2400994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitro.
    Abe Y; Van Eden M; Gatanaga M; Wang FI; Brightbill HD; Granger GA; Gatanaga T
    Lymphokine Cytokine Res; 1993 Oct; 12(5):279-83. PubMed ID: 8260536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.
    Ellis TM; McKenzie RS; Simms PE; Helfrich BA; Fisher RI
    J Immunol; 1989 Dec; 143(12):4282-6. PubMed ID: 2512355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphokine-activated killing by human intestinal lymphocytes.
    Ebert EC; Roberts AI
    Cell Immunol; 1993 Jan; 146(1):107-16. PubMed ID: 7678783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of human T-lymphotropic virus type-1 (HTLV-1)-infected cell line MT-2, which is not killed by a natural killer cell line NK-92 but is killed by lymphokine-activated killer cells.
    Komatsu F; Yoshida S
    Oncol Res; 1999; 11(5):213-8. PubMed ID: 10608615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
    Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
    Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human interleukin-2-activated adherent natural killer cells recognize a conserved antigen found on tumor cells and protozoan parasites.
    Weisman Z; Evans DL; Jaso-Friedmann L
    Nat Immun; 1996-1997; 15(6):269-84. PubMed ID: 9523279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrin formation inhibits the in vitro cytotoxic activity of human natural and lymphokine-activated killer cells.
    Gunji Y; Lewis J; Gorelik E
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):663-72. PubMed ID: 2133246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxicity against autologous, allogeneic, and xenogeneic tumor targets by human recombinant interleukin-2-activated lymphocytes from healthy dogs and dogs with lung tumors.
    Mitchell DH; Withrow SJ; Johnston MR; Kruse CA
    Am J Vet Res; 1991 Jul; 52(7):1132-6. PubMed ID: 1892269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in homing receptor expression on murine lymphokine-activated killer cells during IL-2 exposure.
    Steen PD; McGregor JR; Lehman CM; Samlowski WE
    J Immunol; 1989 Dec; 143(12):4324-30. PubMed ID: 2687380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of human monocyte function against Candida albicans by autologous IL-2-induced lymphokine-activated killer cells.
    Wei S; Serbousek D; McMillen S; Blanchard DK; Djeu JY
    J Immunol; 1991 Jan; 146(1):337-42. PubMed ID: 1898605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of HLA-A, but not of HLA-B, in mouse-human somatic cell hybrids carrying the region p21 leads to pter of human chromosome 6.
    Zmijewski CM; Engel E; Croce CM
    Eur J Immunol; 1978 Aug; 8(8):611-3. PubMed ID: 699957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct evidence for partial target specificity in lymphokine-activated killer thymocytes.
    Leclercq G; De Smedt M; Plum J
    Scand J Immunol; 1990 Oct; 32(4):373-9. PubMed ID: 1700469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CD8+population of LAK cells can lyse both HLA-positive and HLA-negative cancer cell lines.
    Yashin DV; Sashchenko LP; Kabanova OD; Luk'yanovaa TI; Dukhanina EA; Romanova EA; Gnuchev NV
    Dokl Biol Sci; 2009; 426():296-7. PubMed ID: 19650344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.